iShares MSCI Europe IMI Index ETF (TSX: XEU)
Assets | 330.67M |
Expense Ratio | 0.29% |
PE Ratio | 13.46 |
Dividend (ttm) | 0.83 |
Dividend Yield | 2.65% |
Ex-Dividend Date | Dec 28, 2023 |
Payout Frequency | Semi-Annual |
Payout Ratio | 35.72% |
1-Year Return | +13.20% |
Volume | 666 |
Open | 31.04 |
Previous Close | 31.14 |
Day's Range | 31.04 - 31.22 |
52-Week Low | 25.00 |
52-Week High | 31.28 |
Beta | 0.98 |
Holdings | 1287 |
Inception Date | Apr 15, 2014 |
About XEU
The fund provides marketlike exposure to the developed Europe space. The fund tracks a broad MSCI index that invests in large- to small-cap companies, selected and weighted based on their market capitalization. The fund also uses a representative sampling strategy, which means it will invest in a sample of securities that collectively have an investment profile similar to that of the underlying index. In all, XEUs basket provides well-diversified, representative coverage of European stocks across the market cap spectrum. The index is rebalanced quarterly. Sibling fund XEH offers the same exposure but hedged to Canadian dollars.
Performance
XEU had a total return of 13.20% in the past year. Since the fund's inception, the average annual return has been 4.15%, including dividends.
Top 10 Holdings
20.27% of assetsName | Symbol | Weight |
---|---|---|
Novo Nordisk A/S Class B | NOVO B.CO | 3.33% |
ASML Holding NV | ASML.AS | 2.85% |
Nestle SA | NESN.SW | 2.16% |
iShares Core MSCI Europe ETF | IEUR | 2.02% |
AstraZeneca PLC | AZN.L | 1.83% |
Lvmh Moet Hennessy Louis Vuitton SE | MC.PA | 1.81% |
Shell PLC | SHEL.L | 1.79% |
Novartis AG Registered Shares | NOVN.SW | 1.62% |
SAP SE | SAP.DE | 1.51% |
Roche Holding AG | ROG.SW | 1.35% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Dec 28, 2023 | 0.25852 CAD | n/a |
Jun 26, 2023 | 0.570 CAD | n/a |
Dec 29, 2022 | 0.28197 CAD | Jan 5, 2023 |
Jun 24, 2022 | 0.463 CAD | Jun 30, 2022 |
Dec 30, 2021 | 0.28224 CAD | Jan 6, 2022 |
Jun 24, 2021 | 0.403 CAD | Jun 30, 2021 |